17th Jun 2008 16:30
Distribution of Annual Report and Accounts
17th June 2008, Tepnel Life Sciences PLC (AIM: TED), the international Molecular Diagnostics and Research Products & Services group, is pleased to announce that it has distributed its Annual Report and Accounts for the year ended 31st December 2007 to shareholders today. The Annual Report will be available on Tepnel's Investor Relations website in due course.
-Ends-
For further information:
Tepnel Life Sciences plc
Ben Matzilevich, CEO
Michael Slater
Tel: 0161 946 2200
Capital MS&L
Mary Clark or Joanna Whineray
Tel: +44 20 7307 5330
Notes to Editors:
About Tepnel Life Sciences plc
Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences products and services Group with two divisions, Molecular Diagnostics and Research Products & Services. The Company has laboratories, manufacturing and operations in the USA, UK and France with over 200 employees. Tepnel provides test kits, reagents and services to two highly synergistic markets, these being Molecular Diagnostics and Biomedical Research. The Company's strategy has been to identify high growth niche opportunities within these multi-billion pound markets. Tepnel focuses on these niche operations with internally developed products, patents, expertise and know-how as well as strategic acquisitions, to develop a leadership position within these
Related Shares:
TED.L